Cubist Systematic Strategies, LLC Vigil Neuroscience, Inc. Transaction History
Cubist Systematic Strategies, LLC
- $15.1 Billion
- Q4 2024
A detailed history of Cubist Systematic Strategies, LLC transactions in Vigil Neuroscience, Inc. stock. As of the latest transaction made, Cubist Systematic Strategies, LLC holds 24,120 shares of VIGL stock, worth $59,576. This represents 0.0% of its overall portfolio holdings.
Number of Shares
24,120
Previous 15,762
53.03%
Holding current value
$59,576
Previous $53,000
24.53%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding VIGL
# of Institutions
53Shares Held
26.9MCall Options Held
0Put Options Held
0-
Atlas Venture Life Science Advisors, LLC5.84MShares$14.4 Million1.62% of portfolio
-
Northpond Ventures, LLC4.21MShares$10.4 Million51.65% of portfolio
-
Siren, L.L.C. New York, NY1.99MShares$4.92 Million0.15% of portfolio
-
Bvf Inc San Francisco, CA1.81MShares$4.48 Million0.11% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.51MShares$3.72 Million0.0% of portfolio
About Vigil Neuroscience, Inc.
- Ticker VIGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,268,600
- Market Cap $69.8M
- Description
- Vigil Neuroscience, Inc., a microglia-focused company, engages in the development of disease-modifying therapeutics for patients, caregivers, and families affected by rare and common neurodegenerative diseases. Its lead product candidate is VGL101, a fully human monoclonal antibody (mAb) that is designed to activate triggering receptor expressed...